Havn Life Sciences Inc (HAVN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in thousands)
| 01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
| Sales | -12 | 315 | 68 | 216 | 23 |
| Cost of Goods | 71 | 113 | 46 | 148 | 17 |
| Gross Profit | -83 | 202 | 22 | 68 | 6 |
| Operating Expenses | 667 | 940 | 974 | 1,756 | 2,019 |
| Operating Income | -750 | -738 | -952 | -1,688 | -2,013 |
| Interest Expense | 0 | N/A | 14 | 15 | 16 |
| Other Income | 59 | -1,741 | -2,937 | -9,663 | -160 |
| Pre-tax Income | -692 | -2,479 | -3,903 | -11,367 | -2,188 |
| Net Income Continuous | -692 | -2,479 | -3,903 | -11,367 | -2,188 |
| Net Income | $-692 | $-2,479 | $-3,903 | $-11,367 | $-2,188 |
| EPS Basic Total Ops | -0.07 | -0.41 | -27.00 | -2.55 | -0.60 |
| EPS Basic Continuous Ops | -0.07 | -0.41 | -27.00 | -2.55 | -0.60 |
| EPS Diluted Total Ops | -0.07 | -0.41 | -27.00 | -2.55 | -0.60 |
| EPS Diluted Continuous Ops | -0.07 | -0.41 | -27.00 | -2.55 | -0.60 |
| EBITDA(a) | $-691 | $-738 | $-3,843 | $-11,186 | $-2,041 |